Business Angels Marne-Ardennes

We are extremely pleased and enthusiastic that we can count upon the valued support of Business Angels Marne-Ardennes (BAMA, former Reims Business Angels)! 

This enables Apmonia Therapeutics to accelerate the development of its lead candidate AP-01 in solid tumors, while strengthening R&D team and increasing the company’s attractiveness towards industrial partners and investors.


Cancer Biology and Basic Sciences

We are thrilled to announce that Institut national du cancer (INCa) will provide financial support to a unique industry-academic R&D partnership gathering together Apmonia Therapeutics, MEDyC unit (CNRS UMR7369, Université de Reims Champagne-Ardenne, Prof. Stephane Dedieu, PI) and Gustave Roussy Cancer Center (INSERM U981, Dr. Alexandra Leary).

As part of the “Cancer Biology and Basic Sciences” 2020 call for proposals, our ambitious project aims at opening new therapeutic perspectives for the treatment of ovarian cancer, one of the highest unmet medical needs in oncology.

more :